Sugi Predict

Sugi Predict / Compounds / SCHEMBL30511828

SCHEMBL30511828

SCHEMBL30511828

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.61

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 1/20 0.61
▸ NPY2R P49146 1/20 0.61
▸ NPY4R P50391 1/20 0.61
▸ NPY5R Q15761 1/20 0.61
▸ KISS1R Q969F8 4/20 0.61
▸ GLP1R P43220 10/20 0.59
▸ CXCL8 P10145 5/20 0.59
▸ CCKBR P32239 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30607480 0.90 NPY1R (0.61) NPY1RNPY2RNPY4RNPY5RKISS1R
SCHEMBL30262151 0.90 KISS1R (0.59) NPY1RNPY2RNPY4RNPY5RKISS1R
SCHEMBL31182478 0.89 NPY1R (0.67) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL31182989 0.88 NPY1R (0.67) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30277896 0.88 NPY1R (0.62) NPY1RNPY2RNPY4RNPY5RKISS1R
SCHEMBL30906539 0.87 NPY1R (0.67) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906382 0.87 NPY1R (0.66) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30600981 0.86 NPY1R (0.60) NPY1RNPY2RNPY4RNPY5RKISS1R
SCHEMBL30262240 0.86 NPY1R (0.61) NPY1RNPY2RNPY4RNPY5RKISS1R
SCHEMBL30536326 0.86 GLP1R (0.63) KISS1RGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727575-A2 FUSION PROTEINS GENERATING PROTECTIVE ANTIBODIES AND PROTECTIVE TH17 RESPONSES FOR PSEUDOMONAS AERUGINOSA The Children's Medical Center Corporation (US) 2026-04-22 — — EP disclosed
US-20250177443-A1 T CELL RECEPTORS DIRECTED AGAINST JCHAIN AND USES THEREOF ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) 2025-06-05 — — US disclosed
EP-4479142-A1 T CELL RECEPTORS DIRECTED AGAINST JCHAIN AND USES THEREOF Academisch Ziekenhuis Leiden (h.o.d.n. LUMC) (NL) 2024-12-25 — — EP disclosed
WO-2024259229-A2 FUSION PROTEINS GENERATING PROTECTIVE ANTIBODIES AND PROTECTIVE TH17 RESPONSES FOR PSEUDOMONAS AERUGINOSA THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2024-12-19 — — WO disclosed
US-20240110202-A1 Advanced Cell-Permeable Peptide Carriers MUSC FOUNDATION FOR RESEARCH DEVELOPMENT 2024-04-04 — — US disclosed
WO-2023158307-A1 T CELL RECEPTORS DIRECTED AGAINST JCHAIN AND USES THEREOF ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) 2023-08-24 — — WO disclosed
Send feedback